General MedicationsINTRAVENOUSStandard
MOXIFLOXACIN HYDROCHLORIDE
MOXIFLOXACIN HYDROCHLORIDE
Standard Dose
EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Key Takeaways
- Primary indication: Review priority: STANDARD Marketing status: Prescription
- Approval overview MOXIFLOXACIN HYDROCHLORIDE is listed in Drugs@FDA under application 205572 (NDA).
- Review priority: STANDARD Marketing status: Prescription Active ingredient MOXIFLOXACIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2020-03-27 00:00:00.
Structured Monograph
Clinical summary
Approval overview MOXIFLOXACIN HYDROCHLORIDE is listed in Drugs@FDA under application 205572 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient MOXIFLOXACIN HYDROCHLORIDE Form and strength SOLUTION;INTRAVENOUS - EQ 400MG BASE/250ML (EQ 1.6MG BASE/ML) Sponsor FRESENIUS KABI USA Submission history Latest submission status date: 2020-03-27 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.